![]() |
|
|
Vol. 280, Issue 1, 24-31, 1997
Faculty of Pharmacy (J.C., K.S.P.) and
Department of Pharmacology
(K.S.P.), University of Toronto, Toronto, Ontario, Canada
The vascularly perfused rat intestine and liver preparations were used
to examine the effect of flow (8 and 10 ml/min) on the sequential
metabolism of 4-methylumbelliferone (4MU), which forms primarily the
glucuronide conjugate (4MUG) in intestine and the sulfate conjugate
(4MUS) in liver at low input concentrations of 4MU. In this system, a
constant tracer concentration of [3H]4MU was delivered
systemically at 8 or 10 ml/min to the perfused rat small intestine
preparation; the portal venous outflow perfusate at 8 and 10 ml/min was
collected at steady state, reoxygenated and in turn delivered to the
perfused rat liver preparation from a second rat donor. The intestinal
extraction ratio and formation of 4MUG were decreased from 0.57 ± 0.07 to 0.49 ± 0.06 and 42 ± 5 to 36 ± 4% input
rate, respectively, upon increasing the flow rate from 8 to 10 ml/min
(P < .05). These decreases were the result of the reduction in
transit time with increasing flows. In contrast, hepatic 4MU
conjugation was increased (from 40 ± 7% to 48 ± 6% input
rate to intestine) upon increasing the flow rate from 8 and 10 ml/min
(P < .05), attributed primarily to increased formation of the
major metabolite, 4 MUS, in liver (from 35 ± 9% to 39 ± 9% input rate to intestine). The unusual observation on increased hepatic metabolite formation with increasing flow could be
rationalized. With increased flow to the serially perfused organs,
there was an increased supply of substrate to the liver, the posterior
organ, because of a faster intestinal transit time. Decreased
intestinal metabolism (formation of 4MUG) at increased flow was
compensated by increased hepatic metabolism (formation of 4MUS), albeit
attenuated because of a faster hepatic transit time. The proportions of
total 4MU conjugates formed (4MUG + 4MUS) across the intestine and
liver remained constant at both flow rates. Hence, a rather constant overall extraction ratio (0.98 ± 0.004 and 0.97 ± 0.005, P > .05) existed across the two organs. The results demonstrate
that the intestine, the anterior organ, plays a regulatory role on
substrate supply to the posterior organ, the liver. With an increase in flow, the contribution of the intestine will decrease, whereas the
contribution of the liver will increase in the overall first-pass metabolism.
This article has been cited by other articles:
![]() |
H. Sun and K. S. Pang Disparity in Intestine Disposition between Formed and Preformed Metabolites and Implications: A Theoretical Study Drug Metab. Dispos., January 1, 2009; 37(1): 187 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Adachi, H. Suzuki, A. H. Schinkel, and Y. Sugiyama Role of Breast Cancer Resistance Protein (Bcrp1/Abcg2) in the Extrusion of Glucuronide and Sulfate Conjugates from Enterocytes to Intestinal Lumen Mol. Pharmacol., March 1, 2005; 67(3): 923 - 928. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Pang MODELING OF INTESTINAL DRUG ABSORPTION: ROLES OF TRANSPORTERS AND METABOLIC ENZYMES (FOR THE GILLETTE REVIEW SERIES) Drug Metab. Dispos., December 1, 2003; 31(12): 1507 - 1519. [Full Text] [PDF] |
||||
![]() |
J. H. Lin, M. Chiba, and T. A. Baillie Is the Role of the Small Intestine in First-Pass Metabolism Overemphasized? Pharmacol. Rev., June 1, 1999; 51(2): 135 - 158. [Abstract] [Full Text] [PDF] |
||||